Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 24 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
IMMOGYN from Chaudfontaine, company number BE0721754333, closed financial year 2025 with a result of € 16,432 after tax. For that financial year IMMOGYN recorded a gross margin of € 67,287 and equity of € 67,892. Compared with financial year 2024, the result moved from € 16,656 to € 16,432. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 67,892
▲ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16,432
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 20,985
▲ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 7,692.
People and assets in 2025
€ 982
▼ 59% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 475,428
▼ 2% vs 2024
€ 41,304 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 2,179
▼ 55% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 66,454 | € 65,738 | € 70,831 | € 67,287 | ▼ 5% |
| Profit after taxes | € 15,085 | € 14,571 | € 16,656 | € 16,432 | ▼ 1% |
| Equity | € 20,232 | € 34,803 | € 51,460 | € 67,892 | ▲ 32% |
| Total debts | € 670,775 | € 615,996 | € 567,113 | € 555,333 | ▼ 2% |
| Cash | € 2,319 | € 1,744 | € 15,558 | € 20,985 | ▲ 35% |
| Land & buildings | € 625,512 | € 603,615 | € 581,719 | € 559,822 | ▼ 4% |
| Retained profit | € -39,968 | € -25,397 | € -8,740 | € 7,692 | ▲ € 16,432 |
| Bank debt | € 587,718 | € 536,425 | € 484,547 | € 475,428 | ▼ 2% |
| Balance sheet total | € 691,007 | € 650,799 | € 618,573 | € 623,225 | ▲ 1% |
Key figures of IMMOGYN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to IMMOGYN?
What happened at IMMOGYN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Céline MERINDOL stepped down as director. NBB
- Olivier WERY stepped down as director. NBB
- GynécoPP SRL stepped down as director. NBB
- Alix DOUPAGNE stepped down as director. NBB
- Stéphanie JOHNSON stepped down as director. NBB
- Florence HANOCQ stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 16,432 (▼ 1% vs 2024). Source: NBB ↗
- GynécoPP SRL became a director. NBB
In short
From € 15,085 profit in 2022 to € 16,432 profit in 2025.
Best year ever: 2024, with € 16,656 profit.
A new publication or filing at IMMOGYN? We notify you, reason included.
Follow IMMOGYNDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GynécoPP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
IMMOGYNThe shares are held by GynécoPP (14.3%).
Directors
According to the 2025 annual accounts
since 2019 · until 2029
Olivier WERY
Director
since 2019 · until 2029
Director · represented by Pauline PAQUAY
since 2023 · until 2029
Alix DOUPAGNE
Director
since 2019 · until 2029
Stéphanie JOHNSON
Managing director
since 2019 · until 2029
Florence HANOCQ
Director
since 2019 · until 2029
Shareholders
14.3%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Au long pré 65
4053 Chaudfontaine
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0721.754.333
- VAT number
- BE 0721.754.333
- Registered office
- Au long pré 65, 4053 Chaudfontaine
- Names & denominations
- IMMOGYN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 March 2019
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Verhuur en lease van andere machines en werktuigen en andere materiële goederen